Document is current

Article History

Received: 25 April 2020

Accepted: 6 July 2020

First Online: 11 July 2020

Ethics approval and consent to participate

: The study was approved by Vall d’Hebron Ethics Committee. All patients gave their consent for data collection.

: All authors fully comply with and approve the version to be published.

: Torres-Ferrus M has received honoraria as speaker for Allergan, Chiesi, Novartis and Lilly. Gallardo VJ reports no disclosures. Alpuente-Ruiz A has received honoraria as speaker for Allergan. Pozo-Rosich P has received honoraria as a consultant and speaker for: Allergan, Almirall, Amgen, Biohaven, Chiesi, Eli Lilly, Medscape, Neurodiem, Novartis and Teva. Her research group has received research grants from Allergan, and has received funding for clinical trials from Alder, Electrocore, Eli Lilly, Novartis. She is a trustee member of the board of the International Headache Society, member of the Council of the European Headache Society. She is in the editorial board of Revista de Neurologia, associate editor for Cephalalgia, Neurologia, Frontiers of Neurology and Journal of Headache and Pain. She is a member of the Clinical Trials Guidelines Committee of the International Headache Society. She has edited the Guidelines for the Diagnosis and Treatment of Headache of the Spanish Neurological Society. She is the founder of ExternalRef removed. Pozo-Rosich P does not own stocks from any pharmaceutical company.